Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion type Assertion NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_head.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion description "[As part of our HPV-PathogenISS study, a series of 150 squamous cell carcinomas (SCC) and 152 CIN lesions were examined using immunohistochemical (IHC) staining for topoisomerase IIalpha (topo IIalpha), and tested for HPV using PCR with three primer sets (MY09/11, GP5/GP6, SPF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_provenance.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion evidence source_evidence_literature NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_provenance.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion SIO_000772 16990717 NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_provenance.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion wasDerivedFrom befree-20150227 NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_provenance.
- NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_assertion wasGeneratedBy ECO_0000203 NP874703.RAfBG2qd-yTtjleTAd8VLKgVLn9p9eTK4DwF0Mc9eala8130_provenance.